Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralizing activity
- PMID: 2471813
- DOI: 10.1099/0022-1317-70-6-1505
Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralizing activity
Abstract
An important antigenic determinant of human immunodeficiency virus type 1 that induces neutralizing activity in infected humans and chimpanzees was previously mapped with nonapeptides between amino acids 307 and 320 on the external envelope glycoprotein (gp 120) of strain HTLV-IIIB (molecular clone BH10) and amino acids 320 to 330 of strain HTLV-IIIRF. Using different sera we found different reactive nonapeptides that overlapped and shared a tetrapeptide, GPGR. This tetrapeptide, which is the same in HTLV-IIIB and HTLV-IIIRF, is flanked by amino acids that vary between virus strains. Because GPGR is predicted to form a beta-turn and is flanked by two cysteine residues that may form a disulphide bridge, a hairpin-like structure is suggested for this part of gp120. The tetrapeptide GPGR and the reactive peptides are located on top of this structure, well exposed to antibodies. We determined the role of the individual amino acids in antibody binding using three sets of peptide analogues derived from three reactive nonapeptides (two of strain HTLV-IIIB which overlapped and one of strain HTLV-IIIRF). Each set contained peptide analogues in which each amino acid was replaced, one at a time, by all genetically encoded amino acids. At least five consecutive amino acids in each nonapeptide were essential for antibody binding. They include amino acids of GPGR and potentially provide the virus with ample opportunity to escape immune surveillance.
Similar articles
-
Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.Proc Natl Acad Sci U S A. 1988 Jun;85(12):4478-82. doi: 10.1073/pnas.85.12.4478. Proc Natl Acad Sci U S A. 1988. PMID: 2454471 Free PMC article.
-
Immunodominant B-cell clones responsive to an HIV-1 neutralization and cell fusion inhibition epitope in chimpanzee-to-chimpanzee passages of HTLV-IIIB and LAV-1.Res Virol. 1989 Sep-Oct;140(5):405-18. doi: 10.1016/s0923-2516(89)80119-0. Res Virol. 1989. PMID: 2479965
-
Antibody recognition of amino acid divergence within an HIV-1 neutralization epitope.Res Virol. 1989 Sep-Oct;140(5):419-36. doi: 10.1016/s0923-2516(89)80120-7. Res Virol. 1989. PMID: 2479966
-
[Role of the HIV-1 gp120 V1/V2 domains in the induction of neutralizing antibodies].Enferm Infecc Microbiol Clin. 2009 Nov;27(9):523-30. doi: 10.1016/j.eimc.2008.02.010. Epub 2009 May 1. Enferm Infecc Microbiol Clin. 2009. PMID: 19409660 Review. Spanish.
-
Biological consequences of human immunodeficiency virus type 1 envelope polymorphism: does variation matter? 1995 Fleming Lecture.J Gen Virol. 1996 Dec;77 ( Pt 12):2905-19. doi: 10.1099/0022-1317-77-12-2905. J Gen Virol. 1996. PMID: 9000081 Review. No abstract available.
Cited by
-
Characterization of monoclonal antibodies identifying type and strain-specific epitopes of human immunodeficiency virus type 1.Mol Cell Biochem. 1991 Apr 10;102(2):115-23. doi: 10.1007/BF00234569. Mol Cell Biochem. 1991. PMID: 1715507
-
Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies.Immunology. 1991 Aug;73(4):371-6. Immunology. 1991. PMID: 1916888 Free PMC article.
-
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees.J Virol. 1990 Aug;64(8):3779-91. doi: 10.1128/JVI.64.8.3779-3791.1990. J Virol. 1990. PMID: 2370681 Free PMC article.
-
Examination of sera from human immunodeficiency virus type 1 (HIV-1)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of HIV-1 gp120 and for in vitro neutralizing activity.J Virol. 1992 Sep;66(9):5210-5. doi: 10.1128/JVI.66.9.5210-5215.1992. J Virol. 1992. PMID: 1380094 Free PMC article.
-
Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection.J Virol. 1993 Jun;67(6):3345-56. doi: 10.1128/JVI.67.6.3345-3356.1993. J Virol. 1993. PMID: 8497055 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources